Novo Nordisk ® bal GLP-1 market, while GLP-1 varies across regions Thousands GLP-1 share of total estimated diabetes prescriptions 1 is 6% Million prescriptions 1 250 200 Global: 2% 150 Global: 6% 100 50 0 2018 2023 GLP-1 SGLT-2i DPP-4i Insulin Trad. OAD GLP-1 share of estimated diabetes prescriptions 1 The estimated GLP-1 share of prescriptions is based on volume packs from IQVIA. Volume packs are converted into full- year patients/prescriptions based on WHO assumptions for average daily doses or if not available, Novo Nordisk assumptions Source: IQVIA MAT volume (Spot rate), Aug 2023; Market values are based on the list prices
Download PDF file